Does Alpha-1 antitrypsin deficiency increase the risk of pregnancy complications and adverse birth outcomes?
Mothers with Alpha-1 antitrypsin deficiency require close monitoring during pregnancy to reduce the risk of adverse birth outcomes.
This emphasizes the need for mothers with AATD to be monitored closely during pregnancy to reduce the risk of adverse birth outcomes. Routine screening for alpha-1 antitrypsin in pregnancy may be considered among mothers with a pulmonary and liver disease history.
Orimoloye et al. (Tue,) studied this question.